[EN] QUINAZOLINE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS<br/>[FR] DÉRIVÉS DE QUINAZOLINE UTILISÉS EN TANT QU'INHIBITEURS D'ECTONUCLÉOTIDE PYROPHOSPHATASE/PHOSPHODIESTÉRASE 1
申请人:RIBOSCIENCE LLC
公开号:WO2020140001A1
公开(公告)日:2020-07-02
The present disclosure provides certain quinazoline compounds that inhibit ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) enzymatic activity and are therefore useful for the treatment of diseases and conditions modulated at least in part by ENPP1. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Design of small molecule reagents that enable signal amplification via an autocatalytic, base-mediated cascade elimination reaction
作者:Hemakesh Mohapatra、Kyle M. Schmid、Scott T. Phillips
DOI:10.1039/c2cc17566e
日期:——
This Communication describes three small molecule reagents that amplify the signal for a detection event via an autocatalytic reaction. Two signals are obtained from each reagent: (i) the dibenzofulvene chromophore and (ii) piperidine, which can be visualized using a pH indicator dye. The reagents are demonstrated in a model assay for palladium.
本通讯描述了三种小分子试剂,它们通过自催化反应放大检测事件的信号。每种试剂提供两种信号:(i) 二苯基呋喃色素和 (ii) 吡啶,后者可以使用 pH 指示染料进行可视化。这些试剂在钯的模型检测中得到了验证。
INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF CANCER
申请人:Inventiva
公开号:EP3632908A1
公开(公告)日:2020-04-08
The invention relates to compounds of formula (I):
wherein R1; R2, R3, R4, R5 and
are as defined in the description. The compounds of formula (I) are inhibitors of the YAP/TAZ-TEAD interaction and thus useful in the treatment of cancer.
[EN] AMINOGUANIDINE HYDRAZONES AS RETROMER STABILIZERS USEFUL FOR TREATING NEUROLOGICAL DISEASES<br/>[FR] HYDRAZONES D'AMINOGUANIDINE EN TANT QUE STABILISATEURS RÉTROMÈRES UTILES POUR LE TRAITEMENT DE MALADIES NEUROLOGIQUES
申请人:OSPEDALE SAN RAFFAELE SRL
公开号:WO2020201326A1
公开(公告)日:2020-10-08
The present invention relates to novel aminoguanidine hydrazone-derivatives of Formula (I) which are effective as retromer stabilizers and useful as neuroprotecting drugs. The invention also relates to pharmaceutical compositions comprising the compounds and their use in therapy and diagnostic.